Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-03-04 Sale | 2022-03-08 4:13 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer | 32,311 | $7.45 | $240,718 | 263,012 (Direct) | View |
2022-03-04 Sale | 2022-03-08 4:07 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun VP | 33,579 | $7.4517 | $250,219 | 357,036 (Direct) | View |
2022-03-04 Sale | 2022-03-08 4:05 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric VP | 34,792 | $7.4448 | $259,019 | 291,788 (Direct) | View |
2022-03-04 Sale | 2022-03-08 4:04 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven VP | 10,897 | $7.4082 | $80,727 | 408,324 (Direct) | View |
2022-03-04 Sale | 2022-03-08 4:03 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard VP | 58,952 | $7.4382 | $438,494 | 260,879 (Direct) | View |
2022-02-28 Sale | 2022-03-02 07:54 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer | 6,452 | $8.1422 | $52,533 | 58,240 (Direct) | View |
2022-02-28 Sale | 2022-03-02 07:53 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shani Eli VP | 5,311 | $8.1422 | $43,243 | 19,714 (Direct) | View |
2022-02-28 Sale | 2022-03-02 07:47 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun VP | 7,590 | $8.1422 | $61,799 | 108,875 (Direct) | View |
2022-02-28 Sale | 2022-03-02 07:45 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric VP | 9,797 | $8.1422 | $79,769 | 84,859 (Direct) | View |
2022-02-28 Sale | 2022-03-02 07:43 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven VP | 4,862 | $8.1422 | $39,587 | 134,149 (Direct) | View |
2022-02-28 Sale | 2022-03-02 07:41 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard VP | 20,598 | $8.1422 | $167,713 | 61,477 (Direct) | View |
2022-02-08 Sale | 2022-02-10 4:13 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer | 6,110 | $9.0602 | $55,358 | 47,341 (Direct) | View |
2022-02-08 Sale | 2022-02-10 4:09 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun VP | 6,116 | $9.0602 | $55,412 | 102,905 (Direct) | View |
2022-02-08 Sale | 2022-02-10 4:08 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric VP | 3,583 | $9.0605 | $32,464 | 68,631 (Direct) | View |
2022-02-08 Sale | 2022-02-10 4:06 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven VP | 4,138 | $9.0602 | $37,491 | 124,912 (Direct) | View |
2022-02-08 Sale | 2022-02-10 4:05 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard VP | 13,135 | $9.0605 | $119,010 | 63,638 (Direct) | View |
2021-08-10 Sale | 2021-08-12 4:04 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun VP | 50,860 | $9.9493 | $506,021 | 41,412 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-03-04 Option Award | 2022-03-08 4:14 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir CAO | 42,707 | $0 | 80,365 (Direct) | View |
2022-03-04 Exercise | 2022-03-08 4:14 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir CAO | 5,967 | $0 | 80,365 (Direct) | View |
2022-03-04 Option Award | 2022-03-08 4:13 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer | 127,345 | $0 | 263,012 (Direct) | View |
2022-03-04 Exercise | 2022-03-08 4:13 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer | 72,068 | $0 | 263,012 (Direct) | View |
2022-03-04 Option Award | 2022-03-08 4:13 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shani Eli VP | 80,428 | $0 | 119,451 (Direct) | View |
2022-03-04 Exercise | 2022-03-08 4:13 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shani Eli VP | 9,069 | $0 | 119,451 (Direct) | View |
2022-03-04 Option Award | 2022-03-08 4:12 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Schultz Kare CEO | 402,144 | $0 | 2,101,807 (Direct) | View |
2022-03-04 Exercise | 2022-03-08 4:12 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Schultz Kare CEO | 293,586 | $0 | 2,101,807 (Direct) | View |
2022-03-04 Option Award | 2022-03-08 4:11 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark VP | 134,048 | $0 | 398,907 (Direct) | View |
2022-03-04 Exercise | 2022-03-08 4:11 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark VP | 83,042 | $0 | 398,907 (Direct) | View |
2022-03-04 Option Award | 2022-03-08 4:10 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon CFO | 134,048 | $0 | 263,088 (Direct) | View |
2022-03-04 Exercise | 2022-03-08 4:10 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon CFO | 21,387 | $0 | 263,088 (Direct) | View |
2022-03-04 Option Award | 2022-03-08 4:09 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Inbar Galia See Remarks | 80,428 | $0 | 112,926 (Direct) | View |
2022-03-04 Exercise | 2022-03-08 4:09 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Inbar Galia See Remarks | 5,710 | $0 | 112,926 (Direct) | View |
2022-03-04 Option Award | 2022-03-08 4:07 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun VP | 140,750 | $0 | 357,036 (Direct) | View |
2022-03-04 Exercise | 2022-03-08 4:07 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun VP | 94,157 | $0 | 357,036 (Direct) | View |
2022-03-04 Option Award | 2022-03-08 4:05 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric VP | 134,048 | $0 | 291,788 (Direct) | View |
2022-03-04 Exercise | 2022-03-08 4:05 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric VP | 67,034 | $0 | 291,788 (Direct) | View |
2022-03-04 Option Award | 2022-03-08 4:04 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven VP | 154,155 | $0 | 408,324 (Direct) | View |
2022-03-04 Exercise | 2022-03-08 4:04 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven VP | 76,821 | $0 | 408,324 (Direct) | View |
2022-03-04 Option Award | 2022-03-08 4:03 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard VP | 134,048 | $0 | 260,879 (Direct) | View |
2022-03-04 Exercise | 2022-03-08 4:03 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard VP | 81,854 | $0 | 260,879 (Direct) | View |
2022-02-28 Exercise | 2022-03-02 07:55 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir CAO | 4,200 | $0 | 25,029 (Direct) | View |
2022-02-28 Exercise | 2022-03-02 07:54 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer | 18,430 | $0 | 58,240 (Direct) | View |
2022-02-28 Exercise | 2022-03-02 07:53 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shani Eli VP | 5,311 | $0 | 19,714 (Direct) | View |
2022-02-28 Exercise | 2022-03-02 07:51 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Schultz Kare CEO | 65,047 | $0 | 1,262,592 (Direct) | View |
2022-02-28 Exercise | 2022-03-02 07:50 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark VP | 20,598 | $0 | 135,800 (Direct) | View |
2022-02-28 Exercise | 2022-03-02 07:49 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon CFO | 18,430 | $0 | 80,349 (Direct) | View |
2022-02-28 Exercise | 2022-03-02 07:48 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Inbar Galia See Remarks | 4,828 | $0 | 19,313 (Direct) | View |
2022-02-28 Exercise | 2022-03-02 07:47 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun VP | 21,682 | $0 | 108,875 (Direct) | View |
2022-02-28 Exercise | 2022-03-02 07:45 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric VP | 19,514 | $0 | 84,859 (Direct) | View |
2022-02-28 Exercise | 2022-03-02 07:43 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven VP | 17,346 | $0 | 134,149 (Direct) | View |
2022-02-28 Exercise | 2022-03-02 07:41 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard VP | 20,598 | $0 | 61,477 (Direct) | View |
2022-02-13 Exercise | 2022-02-15 07:28 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon CFO | 6,629 | $0 | 38,318 (Direct) | View |
2021-12-31 Ownership | 2022-02-10 4:15 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Zaks Tal Zvi Director | 17 | $8.88 | 17 (Direct) | View |
2022-02-08 Option Award | 2022-02-10 4:13 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer | 37,939 | $0 | 47,341 (Direct) | View |
2022-02-08 Exercise | 2022-02-10 4:13 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer | 12,538 | $0 | 47,341 (Direct) | View |
2022-02-08 Option Award | 2022-02-10 4:12 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Schultz Kare CEO | 162,593 | $0 | 1,230,042 (Direct) | View |
2022-02-08 Exercise | 2022-02-10 4:12 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Schultz Kare CEO | 26,867 | $0 | 1,230,042 (Direct) | View |
2022-02-08 Option Award | 2022-02-10 4:10 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark VP | 43,358 | $0 | 117,363 (Direct) | View |
2022-02-08 Exercise | 2022-02-10 4:10 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark VP | 15,523 | $0 | 117,363 (Direct) | View |
2022-02-08 Option Award | 2022-02-10 4:09 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun VP | 51,488 | $0 | 102,905 (Direct) | View |
2022-02-08 Exercise | 2022-02-10 4:09 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun VP | 16,121 | $0 | 102,905 (Direct) | View |
2022-02-08 Option Award | 2022-02-10 4:08 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric VP | 32,518 | $0 | 68,631 (Direct) | View |
2022-02-08 Exercise | 2022-02-10 4:08 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric VP | 6,568 | $0 | 68,631 (Direct) | View |
2022-02-08 Option Award | 2022-02-10 4:06 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven VP | 37,939 | $0 | 124,912 (Direct) | View |
2022-02-08 Exercise | 2022-02-10 4:06 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven VP | 13,135 | $0 | 124,912 (Direct) | View |
2022-02-08 Option Award | 2022-02-10 4:05 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard VP | 43,358 | $0 | 63,638 (Direct) | View |
2022-02-08 Exercise | 2022-02-10 4:05 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard VP | 13,135 | $0 | 63,638 (Direct) | View |
2021-11-24 Ownership | 2021-12-06 09:42 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir CAO | 0 | $0 | 72,109 (Direct) | View |
2021-11-04 Option Award | 2021-11-08 4:02 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Zaks Tal Zvi Director | 12,205 | $0 | 12,205 (Direct) | View |
2021-11-02 Option Award | 2021-11-04 07:27 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weil Andrew CAO | 29,673 | $0 | 29,673 (Direct) | View |
2021-11-01 Exercise | 2021-11-03 07:25 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Schultz Kare CEO | 180,000 | $0 | 1,156,971 (Direct) | View |
2021-08-15 Ownership | 2021-08-19 4:03 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shani Eli VP | 0 | $0 | 135,141 (Direct) | View |
2021-08-15 Ownership | 2021-08-19 4:02 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Inbar Galia See Remarks | 0 | $0 | 47,860 (Direct) | View |
2021-06-14 Option Award | 2021-06-16 08:23 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Vergis Janet S. Director | 14,479 | $0 | 14,479 (Direct) | View |